Search Results - Tom Dønnem
- Showing 1 - 20 results of 38
- Go to Next Page
-
1
-
2
-
3
-
4
Combination of low vascular endothelial growth factor A (VEGF‐A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor... by Tom Dønnem, Khalid Al‐Shibli, Sigve Andersen, Samer Al‐Saad, Lill‐Tove Busund, Roy M. Bremnes
Published 2010Artigo -
5
-
6
-
7
Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival by Sigve Andersen, Tom Dønnem, Helge Stenvold, Samer Al‐Saad, Khalid A. Alshibli, Lill‐Tove Busund, Roy M. Bremnes
Published 2011Artigo -
8
-
9
High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence by Yngve Nordby, Elin Richardsen, Mehrdad Rakaee, Nora Ness, Tom Dønnem, Hiten Patel, Lill‐Tove Busund, Roy M. Bremnes, Sigve Andersen
Published 2017Artigo -
10
-
11
CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy by Sigurd M. Hald, Roy M. Bremnes, Khalid Al‐Shibli, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Lill‐Tove Busund, Tom Dønnem
Published 2013Artigo -
12
-
13
-
14
The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer by Roy M. Bremnes, Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Sigve Andersen, Rafael Sirera, Carlos Camps, Inigo Marinez, Lill‐Tove Busund
Published 2010Revisão -
15
The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer by Roy M. Bremnes, Khalid Al‐Shibli, Tom Dønnem, Rafael Sirera, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Carlos Camps, Lill‐Tove Busund
Published 2010Revisão -
16
Inverse Prognostic Impact of Angiogenic Marker Expression in Tumor Cells versus Stromal Cells in Non–Small Cell Lung Cancer by Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Marit Pedersen Delghandi, Magnus Persson, Marit N. Nilsen, Lill‐Tove Busund, Roy M. Bremnes
Published 2007Artigo -
17
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer by Thomas K. Kilvaer, Mehrdad Rakaee, Turid Hellevik, Arne Östman, Carina Strell, Roy M. Bremnes, Lill‐Tove Busund, Tom Dønnem, Iñigo Martínez-Zubiaurre
Published 2018Artigo -
18
Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers by Thomas K. Kilvaer, Mehrdad Rakaee, Turid Hellevik, Samer Al‐Saad, Erna‐Elise Paulsen, Roy M. Bremnes, Lill‐Tove Busund, Tom Dønnem, Iñigo Martínez
Published 2015Artigo -
19
Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer by Mehrdad Rakaee, Lill‐Tove Busund, Erna‐Elise Paulsen, Elin Richardsen, Samer Al‐Saad, Sigve Andersen, Tom Dønnem, Roy M. Bremnes, Thomas K. Kilvaer
Published 2016Artigo -
20
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases by Erna‐Elise Paulsen, Thomas K. Kilvaer, Mehrdad Rakaee, Elin Richardsen, Sigurd M. Hald, Sigve Andersen, Lill‐Tove Busund, Roy M. Bremnes, Tom Dønnem
Published 2017Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Cancer research
Pathology
Cancer
Oncology
Immunohistochemistry
Tissue microarray
Biology
Lung cancer
Stromal cell
Immune system
Immunology
Gene
Multivariate analysis
Prostate cancer
Univariate analysis
Biochemistry
Angiogenesis
CD8
Lymph node
Metastasis
Paleontology
Prostate
Stage (stratigraphy)
Genetics
Prostatectomy
microRNA
Confidence interval
Hazard ratio